
Madeca21
Madeca21 is a skincare line by Dongkook Pharmaceutical, known for its use of centella asiatica extract (TECA), derived from their popular wound treatment ointment, Madecassol. The brand was launched in 2018, following the success of Madeca Cream. Madeca21 products are designed to be gentle and effective, particularly for soothing and moisturizing sensitive skin.